thiazoles has been researched along with gw 590735 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beneton, V; Boullay, AB; Boyer, T; Brewster, AG; Donche, F; Forest, MC; Fouchet, MH; Gellibert, FJ; Grillot, DA; Lambert, MH; Laroze, A; Le Grumelec, C; Linget, JM; Montana, VG; Nguyen, VL; Nicodème, E; Patel, V; Penfornis, A; Pianetti, PM; Pineau, O; Pohin, D; Potvain, F; Poulain, G; Ruault, CB; Saunders, M; Sierra, ML; Toum, J; Xu, HE; Xu, RX | 1 |
Billin, AN | 1 |
Headey, SJ; Rimmer, KA; Velkov, T | 1 |
Barone, FC; Brusq, JM; Grillot, DA; Hansen, MK; Issandou, M; Legos, JJ; McVey, MJ; White, RF | 1 |
1 review(s) available for thiazoles and gw 590735
Article | Year |
---|---|
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home.
Topics: Animals; Atherosclerosis; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dyslipidemias; Glucose; Humans; Insulin Resistance; Lipoproteins; PPAR delta; PPAR-beta; Propionates; Thiazoles | 2008 |
3 other study(ies) available for thiazoles and gw 590735
Article | Year |
---|---|
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents.
Topics: Animals; Apolipoprotein A-I; Cholesterol, HDL; Cholesterol, VLDL; Crystallography, X-Ray; Dogs; Dyslipidemias; Humans; Ligands; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Molecular; PPAR alpha; Propionates; Protein Structure, Tertiary; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles; Triglycerides | 2007 |
Ligand-enhanced expression and in-cell assay of human peroxisome proliferator-activated receptor alpha ligand binding domain.
Topics: Butyrates; Fatty Acids, Unsaturated; Fenofibrate; Humans; Ligands; Maltose-Binding Proteins; Mediator Complex Subunit 1; Models, Molecular; Periplasmic Binding Proteins; Phenylurea Compounds; PPAR alpha; Propionates; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; Thiazoles | 2010 |
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Fenofibrate; Humans; Mice; Mice, Transgenic; PPAR alpha; Propionates; Quinolines; Thiazoles | 2010 |